Fidelity SAI International Low Volatility Index Fund (FSKLX) is an open-end mutual fund that seeks investment results corresponding to the total return performance of the Fidelity International Low Volatility Focus Index, emphasizing equity securities of low-volatility issuers in developed markets outside the United States. The fund normally invests at least 80% of its assets in common stocks included in the index, which reflects the performance of large- and mid-cap stocks exhibiting lower volatility relative to the broader international large- and mid-cap equity markets; it also employs derivatives such as futures contracts for exposure and risk management. Its portfolio is diversified across sectors including healthcare, consumer defensive, utilities, and basic materials, with top holdings such as AstraZeneca PLC, Novartis AG, Unilever PLC, Roche Holding AG, and National Grid PLC; non-US stocks comprise approximately 97.7% of assets, cash 1.5%, and US stocks 0.8%. Launched on May 29, 2015, the fund is domiciled and managed in the United States by Fidelity Management & Research Company LLC, part of the Fidelity Investments family, with total net assets of approximately $5.74 billion and a low net expense ratio of 0.16%.
The fund targets investors seeking international equity exposure with reduced volatility characteristics compared to standard foreign large-blend benchmarks like the MSCI ACWI ex USA Index, serving as a cost-effective core holding for institutional and individual portfolios focused on risk-managed global diversification. Geographically, it operates primarily in developed markets across Europe, Japan, and other non-US regions, excluding emerging markets. No significant recent acquisitions, partnerships, funding rounds, product launches, or strategic reorganizations have been reported for the fund in the last 1-2 years; it continues to maintain its index-tracking strategy amid stable assets under management growth.